Search Within

Gary Schwartz

Formats
  1. Journal Article (191)
  2. Meeting Abstract (190)
  3. Conference Paper (3)
  4. Book Section (1)
Groups
  1. Department of Medicine (215)
  2. Solid Tumor Oncology Division (205)
  3. Melanoma Disease Management Team (129)
  4. Center for Pancreatic Cancer Research (99)
  5. Gastrointestinal Oncology Service (99)
  6. GSK Faculty (91)

More Groups

People
  1. David Kelsen (79)
  2. Richard Carvajal (61)
  3. Manish Shah (41)
  4. Mark Dickson (40)
  5. Eileen O'Reilly (36)
  6. Monica Motwani (36)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2018 (2)
  4. 2016 (3)
  5. 2015 (5)
  6. 2014 (23)

More Years

Publications
  1. Journal of Clinical Oncology (103)
  2. Cancer Research (42)
  3. Clinical Cancer Research (39)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (30)
  5. Annals of Oncology (12)
  6. Cancer (12)

More Publications

Publishers
  1. American Association for Cancer Research (121)
  2. American Society of Clinical Oncology (105)
  3. Elsevier Inc. (20)
  4. Springer (20)
  5. Oxford University Press (16)
  6. Wiley Blackwell (15)

More Publishers

Results (385)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cell cycle modulation: An emerging target for cancer therapy
    Journal Article

    Shah, M. A.; Schwartz, G. K.
    Horizons in Cancer Therapeutics: From Bench to Bedside (2003)

    Fulltext@MSK | Save
  • Development of cell cycle inhibitors in the treatment of gastrointestinal cancers
    Journal Article

    Schwartz, G. K.
    Journal of Clinical Ligand Assay (2003)

    Fulltext@MSK | Save
  • Cyclin-dependent kinases as targets for cancer therapy
    Journal Article

    Shah, M. A.; Schwartz, G. K.
    Cancer Chemotherapy and Biological Response Modifiers (2003)

    Fulltext@MSK | Save
  • Bryostatin-1: A novel PKC inhibitor in clinical development
    Journal Article

    Kortmansky, J.; Schwartz, G. K.
    Cancer Investigation (2003)

    Fulltext@MSK | Save
  • Flavopiridol enhances the effect of docetaxel in Vitro and in Vivo in human gastric cancer cells
    Journal Article

    Motwani, M.; Rizzo, C.; Sirotnak, F.; She, Y.; Schwartz, G. K.
    Molecular Cancer Therapeutics (2003)

    Fulltext@MSK | Save
  • The cyclin-dependent kinase inhibitor flavopiridol potentiates γ-irradiation-induced apoptosis in colon and gastric cancer cells
    Journal Article

    Jung, C.; Motwani, M.; Kortmansky, J.; Sirotnak, F. M.; She, Y.; Gonen, M.; Haimovitz-Friedman, A.; Schwartz, G. K.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Irinotecan in metastatic colorectal cancer: Dose intensification and combination with new agents, including biological response modifiers
    Conference Paper

    Ducreux, M.; Köhne, C. H.; Schwartz, G. K.; Vanhoefer, U.
    Oxford University Press (2003)

    Fulltext@MSK | Save
  • Abrogation of the G2/M checkpoint by 7-hydroxystaurosporine (UCN-01) on SN-38 treated cells: A strategy for targeting tumors with defective cell cycle checkpoints
    Meeting Abstract

    Tse, A. N.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • The identification of Drg1 as a gene that modulates chemotherapy-induced apoptosis: A new target for cancer therapy
    Meeting Abstract

    Motwani, M. V.; Sirotnak, F.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • Response to the combination of bryostatin-1 and paclitaxel is dose-dependent
    Meeting Abstract

    Kortmansky, J.; Shah, M.; Ilson, D.; Kaubisch, A.; Endres, S.; Welch, M.; Gonen, M.; Kelsen, D. P.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save